Updated Meta-Analysis Assessing Effects of Baduanjin on Cardiopulmonary Functions of Patients with Coronary Heart Disease

Table 2

Subgroup analyses results of LVEF.

Outcomes	No. of study	WMD (95% CI)	value	Heterogeneity test
				I^2 (%)	PH
Follow-up, months
<1 month	2	5.09 (−0.40, 10.58)	0.07	57	0.13
3 months	4	4.18 (2.10, 6.26)	<0.0001	77	0.004
6 months	2	2.70 (0.38, 5.02)	0.02	0	0.34
Rehabilitation scheme
Baduanjin vs. control	6	4.13 (2.12, 6.24)	<0.0001	70	0.005
Baduanjin + AT vs. AT	2	3.21 (1.24, 5.18)	0.001	0	0.82
New-onset
Yes	2	1.94 (−0.94, 4.82)	0.19	0	0.54
No	6	4.32 (2.62, 6.03)	<0.00001	67	0.010

AT, aerobic training; CI, confidence interval; WMD, weighted mean difference.